Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Tesla Says Gaining Rapid Traction In 4680 Cell Production

News

Tesla Says Gaining Rapid Traction In 4680 Cell Production

-Conference Call

byMichael Horton

October 19, 2022

1 minute read

-Conference Call

NIO Q3 Adj. EPADS $(0.30) Misses $(0.16) Estimate, Sales $1.83B Beat $1.79B Estimate

By Benzinga Newsdesk

November 10, 6:03 AM

NIO (NYSE:NIO) reported quarterly adjusted losses per ADS of $(0.30) per share which missed the analyst consensus estimate of $(0.16) by 87.5 percent. This is a 400 percent decrease over losses of $(0.06) per ADS from

NIO

HC Wainwright & Co. Maintains Buy on Outlook Therapeutics, Maintains $5 Price Target

By Benzinga Newsdesk

February 15, 7:14 AM

HC Wainwright & Co. analyst Douglas Tsao maintains Outlook Therapeutics (NASDAQ:OTLK) with a Buy and maintains $5 price target.

OTLK

Movers
News

Why ZoomInfo Technologies Shares Are Falling Today

By Erica Kollmann

August 1, 12:57 PM

ZoomInfo Technologies, Inc. (NASDAQ: ZI) shares are trading lower Tuesday after the company issued weak guidance and several analysts lowered their ZI price targ

News

Transocean Says As Of Apr. 18, Co.’s Total Backlog Is ~$8.6B

By Michael Horton

April 18, 4:23 PM

This quarter's report includes the following updates: Transocean Enabler – Awarded a 19-well contract in Norway at a current rate of $377,000 per day, as adjusted for foreign currency exchange

RIG

Tesla Says Gaining Rapid Traction In 4680 Cell Production

Related Posts

NIO Q3 Adj. EPADS $(0.30) Misses $(0.16) Estimate, Sales $1.83B Beat $1.79B Estimate

HC Wainwright & Co. Maintains Buy on Outlook Therapeutics, Maintains $5 Price Target

Why ZoomInfo Technologies Shares Are Falling Today

Transocean Says As Of Apr. 18, Co.’s Total Backlog Is ~$8.6B